companydata.dkcompanydata.dk

UV Clinical A/S: Financial statements 2021

CVR: 38401572

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

UV Clinical A/S (CVR 38401572) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 33,464 and a net result of DKK 2,248,332 compared with DKK -1,149,248 the year before. Equity in the 2021 report amounted to DKK 123,871. The solvency ratio was 77.5%. The company had 1 employee in the financial year.

Gross Profit
DKK 33,464
Profit/Loss
DKK 2,248,332
Equity
DKK 123,871
Total Assets
DKK 159,793
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-33K2.2M124K1
2020--411K-1.1M-2.1M1
2019--577K-1.4M-975K1
2018-4K-799K-584K1
2017--376K-1.1M215K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like UV Clinical A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Carsten Viftrup Andersen joins the board of UV Clinical A/SDec 22, 2021

As of December 22, 2021, Carsten Viftrup Andersen has joined the board of directors of UV Clinical A/S.

Claus Frisenberg Pedersen joins the board of UV Clinical A/SNov 22, 2021

As of November 22, 2021, Claus Frisenberg Pedersen has joined the board of directors of UV Clinical A/S.

UV Clinical A/S appoints new auditorSep 6, 2021

As of September 6, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of UV Clinical A/S.

Auditor steps down at UV Clinical A/SSep 6, 2021

As of September 6, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of UV Clinical A/S.

Helge Holm-Larsen joins the board of UV Clinical A/SSep 6, 2021

As of September 6, 2021, Helge Holm-Larsen has joined the board of directors of UV Clinical A/S.

Rolf Henrik Sprunk-Jansen joins UV Clinical A/S as directorAug 2, 2021

As of August 2, 2021, Rolf Henrik Sprunk-Jansen is registered as director of UV Clinical A/S.

Jimmy Bak steps down as director of UV Clinical A/SAug 2, 2021

As of August 2, 2021, Jimmy Bak has stepped down as director of UV Clinical A/S.

Helge Holm-Larsen leaves the board of UV Clinical A/SJul 12, 2021

As of July 12, 2021, Helge Holm-Larsen has left the board of directors of UV Clinical A/S.

Rolf Henrik Sprunk-Jansen joins the board of UV Clinical A/SJul 9, 2021

As of July 9, 2021, Rolf Henrik Sprunk-Jansen has joined the board of directors of UV Clinical A/S.

Jan Friis Schack leaves the board of UV Clinical A/SJul 9, 2021

As of July 9, 2021, Jan Friis Schack has left the board of directors of UV Clinical A/S.

About UV Clinical A/S

UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.

Source: annual report 2025, Danish Business Authority